Posted by Hugo Ottolenghi
September 27th, 2009
How closely can nutritional supplement companies connect with the fast-moving world of social media? The FDA will address these questions at a hearing Nov. 12-13 in Washington. The agency is soliciting comments in the Federal Register.
Posted by Hugo Ottolenghi
August 31st, 2009
This is a tale of two types of weight-loss products and how the Food and Drug Administration had different responses to similar problems with them. The separate, but not equivalent treatment raises questions about how the FDA operates.
Posted by Hugo Ottolenghi
May 27th, 2009
In the days following the FDA warning on the dangers of taking Hydroxycut and the manufacturer’s recall, the reaction has been more sliced than divided. There were the oft-seen reactions: NaturalNews headlined its commentary, “FDA Floats Hydroxycut Scare to Discredit Yet Another Supplement Company.” The personal injury law firm of Onder Shelton O’Leary & Peterson [...]
Posted by Hugo Ottolenghi
March 26th, 2009
When it comes to dietary supplements, it’s like the Wild West, and the bad guys know they don’t have to take the sheriff seriously.
Industry and consumer voices are split in their interpretations of a GAO report on how the FDA should regulate dietary supplements. All sides agree that the FDA needs more resources, but they [...]
Posted by Vincent Annunziata
December 13th, 2008
Although Section 403(y) of the Federal Food, Drug, and Cosmetic Act (FFD&C Act) (21 U.S.C. 343(y), does not require a dietary supplement label to include anything other than a domestic address or phone number for the responsible person, the FDA recommends that the label also bear a clear, prominent statement informing consumers that [...]